BridgeBio Pharma Total Non-Operating Income/Expense 2018-2024 | BBIO
BridgeBio Pharma total non-operating income/expense for the twelve months ending June 30, 2024 was $0.049B, a 191.04% decline year-over-year.
- BridgeBio Pharma annual total non-operating income/expense for 2023 was $-0.046B, a 266.54% decline from 2022.
- BridgeBio Pharma annual total non-operating income/expense for 2022 was $0.028B, a 380.49% decline from 2021.
- BridgeBio Pharma annual total non-operating income/expense for 2021 was $-0.01B, a 68.32% decline from 2020.